The Brief
What Tempus AI Next does and why it matters
Tempus Next uses AI to recommend the most effective next treatment for cancer patients based on genomic data, treatment history, and real-world evidence from similar patients in the Tempus database.
Builder’s Brief
Tempus AI Next is a healthcare tool on Falcoscan. AI-powered next best therapy recommendations for oncology. Falcoscan rates Tempus AI Next with an Opportunity score of 88/100, a Saturation score of 8/100, and a Wrapper-risk score of 6/100. Market signal: hot. Tempus AI Next is founded in 2023, currently at Series_a stage. Pricing: Paid. Rating 4.7/5 across 1 tracked views.